XML 52 R39.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Mar. 29, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
(In thousands)PlasmaBlood CenterHospitalTotal
Carrying amount as of April 1, 2023$29,043 $33,855 $403,333 $466,231 
Acquisitions— — 87,079 87,079 
Purchase accounting adjustments— — 12,283 12,283 
Currency translation— (371)(140)(511)
Carrying amount as of March 30, 202429,043 33,484 502,555 565,082 
Divestitures— (6,381)— (6,381)
Acquisitions— — 69,542 69,542 
Purchase accounting adjustments— — (19,248)(19,248)
Currency translation— (136)(4,590)(4,726)
Carrying amount as of March 29, 2025$29,043 $26,967 $548,259 $604,269 
Schedule of Amoritized Intangibles
The gross carrying amount of intangible assets and the related accumulated amortization as of March 29, 2025 and March 30, 2024 is as follows:
(In thousands)Gross Carrying
Amount
Accumulated
Amortization
Net
As of March 29, 2025  
Amortizable:
Developed technology$506,143 $156,123 $350,020 
Customer contracts and related relationships135,561 70,842 64,719 
Capitalized software85,528 76,185 9,343 
Patents and other19,678 6,796 12,882 
Trade names15,955 6,367 9,588 
Total$762,865 $316,313 $446,552 
Non-amortizable:
In-process software development9,190 
Total$9,190 
(In thousands)Gross Carrying
Amount
Accumulated
Amortization
Net
As of March 30, 2024  
Amortizable:
Developed technology$464,291 $178,413 $285,878 
Customer contracts and related relationships255,144 190,033 65,111 
Capitalized software84,837 69,491 15,346 
Patents and other24,504 11,820 12,684 
Trade names14,320 5,456 8,864 
Total$843,096 $455,213 $387,883 
Non-amortizable:
In-process research and development$13,667 
In-process software development4,567 
Total$18,234 
Schedule of Future Amortization Expense
Amortization expense on intangible assets for the next five years is estimated to be as follows:
(In thousands)
Fiscal 2026$51,563 
Fiscal 2027$47,344 
Fiscal 2028$45,568 
Fiscal 2029$44,320 
Fiscal 2030$43,410